SEC Form 4 · accession 0001179110-16-028600
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael David Staffieri
Officer — COO, Kidney Care
Period of report
Aug 9, 2016
Accepted (ET)
Aug 11, 2016 · 6:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 9, 2016 | M | 40,000 | $37.185 | A | 52,279 | D | |
| Common Stock | Aug 9, 2016 | F | 19,738 | $75.36 | D | 32,541 | D | |
| Common StockF2 | Aug 9, 2016 | S | 20,262 | $73.0872 | D | 12,279 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF3 | $37.185 | Aug 9, 2016 | M | 40,000 | D | Aug 9, 2014 | Aug 9, 2016 | Common Stock | 40,000 | 0 | D |
Explanation of responses
- F1The exercise and sale reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2016.
- F2Represents the weighted average sale price of $73.0872. The range of prices for the sale of these shares was $72.43 - $73.93, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F3The Stock Appreciation Rights were granted on 8/9/2011. 50% vested on 8/9/2014, then 8.33% vested every three months thereafter.